Scholarlink

<p>At this year’s ASCO Annual Meeting, researchers presented detailed findings concerning biomarkers and rare subtypes of renal cell carcinoma. Identifying a&#xa0;unique biomarker can be a&#xa0;challenging endeavor, but patients with metastatic RCC are living longer due to the availability of multiple therapeutic options.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Biomarkers and treatment updates in renal cell carcinoma

  • 期刊论文

  • 发表日期：

    2025年1月30日

查看全文
  • Jasmin Alija Spiegelberg

摘要

At this year’s ASCO Annual Meeting, researchers presented detailed findings concerning biomarkers and rare subtypes of renal cell carcinoma. Identifying a unique biomarker can be a challenging endeavor, but patients with metastatic RCC are living longer due to the availability of multiple therapeutic options.